MUX Form 4: Stephen Kaszas Receives 10,000 Stock Options, Vesting 20262030

Rhea-AI Filing Summary

Stephen Douglas Kaszas, a director of McEwen Inc. (MUX), was granted a stock option on 08/11/2025 to buy 10,000 shares of common stock at an exercise price of $10.43. The Form 4 reports the option as an acquisition and shows 10,000 derivative securities beneficially owned following the transaction, held directly. The option vests in three equal annual installments beginning August 11, 2026 and the option expires on August 11, 2030. The filing was made by one reporting person and identifies Kaszasrelationship to the issuer as a director.

Insights

Financial Analyst

TL;DR: Routine director option grant of 10,000 shares at $10.43 with a three-year vesting schedule and 2030 expiration.

The Form 4 documents a non-derivative change via a derivative grant: a stock option issued 08/11/2025 for 10,000 common shares at an exercise price of $10.43. The option vests in three equal annual installments beginning 08/11/2026 and shows direct beneficial ownership of 10,000 derivative securities following the transaction. As presented, the filing is a straightforward disclosure of compensation-related equity awarded to a director; all details below are explicit in the filing.

Corporate Governance Expert

TL;DR: Form 4 reports a standard director award with explicit vesting and expiration terms; disclosure is complete on key grant terms.

The disclosure identifies Stephen Douglas Kaszas as the reporting person and a director of McEwen Inc. It records an acquisition (option grant) dated 08/11/2025 for 10,000 stock options at an exercise price of $10.43, vesting in three equal annual installments starting 08/11/2026 and expiring 08/11/2030. The filing indicates the ownership form as Direct and was filed by one reporting person, meeting the Form 4 reporting requirement for changes in beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaszas Stephen Douglas

(Last) (First) (Middle)

C/O MCEWEN INC.

150 KING STREET WEST, SUITE 2800

(Street)

TORONTO A6 M5H 1J9

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
McEwen Inc. [ MUX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$10.43	08/11/2025		A		10,000		(1)	08/11/2030	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. The option vests in three equal annual installments, beginning August 11, 2026.

	/s/ Stephen Douglas Kaszas	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the McEwen Inc. (MUX) Form 4 filed by Stephen Kaszas report?

The Form 4 reports a stock option grant to Stephen Douglas Kaszas for 10,000 common shares at an exercise price of $10.43, dated 08/11/2025.

How many options were granted to Stephen Kaszas and at what price?

10,000 stock options were granted with an exercise price of $10.43.

When do the options vest according to the filing?

The options vest in three equal annual installments beginning on August 11, 2026.

What is the expiration date of the options granted to Kaszas?

The options expire on August 11, 2030.

What ownership is reported after the transaction on the Form 4?

The filing shows 10,000 derivative securities beneficially owned following the transaction, held directly.